This summary was created by AI, based on 2 opinions in the last 12 months.
Experts have mixed opinions on Cameco Corp. (US) with one suggesting it as the best uranium play, while another deems it too speculative. The company is seen as beneficiary of increased investor interest in uranium, but there are concerns about the feasibility of building nuclear reactors. Overall, there seems to be uncertainty about the future prospects of the stock.
Too speculative though he missed the 21% rally over the past 3 months. Already uranium stocks a headwind in that it's almost impossible to build a nuclear reactor, though some will disagree.
Cameco Corp. (US) is a American stock, trading under the symbol CCJ-N on the New York Stock Exchange (CCJ). It is usually referred to as NYSE:CCJ or CCJ-N
In the last year, 2 stock analysts published opinions about CCJ-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cameco Corp. (US).
Cameco Corp. (US) was recommended as a Top Pick by on . Read the latest stock experts ratings for Cameco Corp. (US).
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Cameco Corp. (US) In the last year. It is a trending stock that is worth watching.
On 2024-03-28, Cameco Corp. (US) (CCJ-N) stock closed at a price of $43.32.
The best uranium play, and investors now want to invest in uranium.